Back to Search
JAN CERNY, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1407887771IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
227024(MA)
Education
OTHER
Class of 1999
Research & Publications (20)
Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders.
PMID 19635181·Hematology·2009
8-other
Coronary vasospasm with myocardial stunning in a patient with colon cancer receiving adjuvant chemotherapy with FOLFOX regimen.
PMID 19203898·Clin Colorectal Cancer·2009
5-case
Clinicopathological features of extramedullary recurrence/relapse of multiple myeloma.
PMID 18462256·Eur J Haematol·2008
5-case
Biallelic IgH rearrangements in patients with indolent lymphoproliferative disorders: molecular and practical implications.
PMID 15040004·J Cell Physiol·2004
4-observational
The small chemical vacuolin-1 inhibits Ca(2+)-dependent lysosomal exocytosis but not cell resealing.
PMID 15332114·EMBO Rep·2004
7-preclinical
Chemotherapy alone may lead to a PCR negative stem cell harvest in transformed lymphoma refractory to rituximab.
PMID 12651284·Haematologica·2003
5-case
Unusual sequence of VDJ rearrangement revealed by molecular analysis in a patient with indolent lymphoma.
PMID 12745284·Haematologica·2003
5-case
The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: a prospective study.
PMID 19232722·Leuk Res·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 55 LAKE AVE N
WORCESTER, MA 01655 - Phone
- (774) 442-3903
Quick Facts
- NPI
- 1407887771
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile